Login
Home
Charts
Search
Watchlist
Products

National Peroxide Ltd

NPL·BSE
594.80-0.68%Wed, 23 Sept '26

National Peroxide Ltd

NPL
BSE
594.80
-0.68%
|Wed, 23 Sept '26
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
343Cr
Close
Close Price
596.00
Industry
Industry
Chemicals - Inorganic
PE
Price To Earnings
18.97
PS
Price To Sales
1.07
Revenue
Revenue
319Cr
Rev Gr TTM
Revenue Growth TTM
14.16%
PAT Gr TTM
PAT Growth TTM
380.43%

Quarterly Results

Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
828488747762746768698696
Growth YoY
Revenue Growth YoY%
-0.3-7.0-5.8-25.7-16.3-9.9-11.311.216.344.1
Expenses
ExpensesCr
737479647359766264627184
Operating Profit
Operating ProfitCr
9991043-25571512
OPM
OPM%
11.011.310.313.85.35.2-3.27.36.610.117.412.7
Other Income
Other IncomeCr
210220022012
Interest Expense
Interest ExpenseCr
100000000000
Depreciation
DepreciationCr
555555555555
PBT
PBTCr
65471-2-8112119
Tax
TaxCr
211200-100012
PAT
PATCr
45351-2-610297
Growth YoY
PAT Growth YoY%
-71.512.4-84.7-131.9-311.4-82.5-42.6220.4242.2642.7
NPM
NPM%
5.45.73.56.90.9-2.5-8.81.30.62.610.86.9
EPS
EPS
7.78.35.38.81.2-2.6-11.31.60.73.216.111.5
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
828488747762746768698696
Growth YoY
Revenue Growth YoY%
-0.3-7.0-5.8-25.7-16.3-9.9-11.311.216.344.1
Expenses
ExpensesCr
737479647359766264627184
Operating Profit
Operating ProfitCr
9991043-25571512
OPM
OPM%
11.011.310.313.85.35.2-3.27.36.610.117.412.7
Other Income
Other IncomeCr
210220022012
Interest Expense
Interest ExpenseCr
100000000000
Depreciation
DepreciationCr
555555555555
PBT
PBTCr
65471-2-8112119
Tax
TaxCr
211200-100012
PAT
PATCr
45351-2-610297
Growth YoY
PAT Growth YoY%
-71.512.4-84.7-131.9-311.4-82.5-42.6220.4242.2642.7
NPM
NPM%
5.45.73.56.90.9-2.5-8.81.30.62.610.86.9
EPS
EPS
7.78.35.38.81.2-2.6-11.31.60.73.216.111.5

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
00377333287290319
Growth
Revenue Growth%
-11.7-13.81.014.2
Expenses
ExpensesCr
00317295272265281
Operating Profit
Operating ProfitCr
006038152439
OPM
OPM%
15.811.35.38.412.1
Other Income
Other IncomeCr
00215455
Interest Expense
Interest ExpenseCr
0072211
Depreciation
DepreciationCr
002019202121
PBT
PBTCr
005422-2722
Tax
TaxCr
00145024
PAT
PATCr
004017-2618
Growth
PAT Growth%
-15.44,76,022.9-57.5-113.4359.3380.4
NPM
NPM%
10.55.0-0.82.05.7
EPS
EPS
-7.2-8.368.729.2-3.910.131.4
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
00377333287290319
Growth
Revenue Growth%
-11.7-13.81.014.2
Expenses
ExpensesCr
00317295272265281
Operating Profit
Operating ProfitCr
006038152439
OPM
OPM%
15.811.35.38.412.1
Other Income
Other IncomeCr
00215455
Interest Expense
Interest ExpenseCr
0072211
Depreciation
DepreciationCr
002019202121
PBT
PBTCr
005422-2722
Tax
TaxCr
00145024
PAT
PATCr
004017-2618
Growth
PAT Growth%
-15.44,76,022.9-57.5-113.4359.3380.4
NPM
NPM%
10.55.0-0.82.05.7
EPS
EPS
-7.2-8.368.729.2-3.910.131.4

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
006666
Reserves
ReservesCr
00346353344351
Current Liabilities
Current LiabilitiesCr
0041413750
Non Current Liabilities
Non Current LiabilitiesCr
0061595652
Total Liabilities
Total LiabilitiesCr
00454459442459
Current Assets
Current AssetsCr
00114120121139
Non Current Assets
Non Current AssetsCr
00340339321320
Total Assets
Total AssetsCr
00454459442459
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
006666
Reserves
ReservesCr
00346353344351
Current Liabilities
Current LiabilitiesCr
0041413750
Non Current Liabilities
Non Current LiabilitiesCr
0061595652
Total Liabilities
Total LiabilitiesCr
00454459442459
Current Assets
Current AssetsCr
00114120121139
Non Current Assets
Non Current AssetsCr
00340339321320
Total Assets
Total AssetsCr
00454459442459

Cash Flow

Standalone
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
0067361934
Investing Cash Flow
Investing Cash FlowCr
0025-18-2-23
Financing Cash Flow
Financing Cash FlowCr
00-86-17-13-5
Net Cash Flow
Net Cash FlowCr
006246
Free Cash Flow
Free Cash FlowCr
0061221430
CFO To PAT
CFO To PAT%
0.095.2169.9216.8-831.0587.9
CFO To EBITDA
CFO To EBITDA%
0.095.2112.496.8122.7141.3
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
0067361934
Investing Cash Flow
Investing Cash FlowCr
0025-18-2-23
Financing Cash Flow
Financing Cash FlowCr
00-86-17-13-5
Net Cash Flow
Net Cash FlowCr
006246
Free Cash Flow
Free Cash FlowCr
0061221430
CFO To PAT
CFO To PAT%
0.095.2169.9216.8-831.0587.9
CFO To EBITDA
CFO To EBITDA%
0.095.2112.496.8122.7141.3

Ratios

Standalone
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
332202343
Price To Earnings
Price To Earnings
34.619.0
Price To Sales
Price To Sales
1.20.71.1
Price To Book
Price To Book
0.90.60.9
EV To EBITDA
EV To EBITDA
21.37.78.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
33.930.224.929.329.3
OPM
OPM%
15.811.35.38.412.1
NPM
NPM%
10.55.0-0.82.05.7
ROCE
ROCE%
-256.3150.916.16.3-0.12.42.4
ROE
ROE%
-256.3150.911.24.7-0.61.61.6
ROA
ROA%
-71.9-395.28.73.7-0.51.31.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
332202343
Price To Earnings
Price To Earnings
34.619.0
Price To Sales
Price To Sales
1.20.71.1
Price To Book
Price To Book
0.90.60.9
EV To EBITDA
EV To EBITDA
21.37.78.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
33.930.224.929.329.3
OPM
OPM%
15.811.35.38.412.1
NPM
NPM%
10.55.0-0.82.05.7
ROCE
ROCE%
-256.3150.916.16.3-0.12.42.4
ROE
ROE%
-256.3150.911.24.7-0.61.61.6
ROA
ROA%
-71.9-395.28.73.7-0.51.31.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
National Peroxide Limited is India’s original and largest maker of hydrogen peroxide - the workhorse bleaching and oxidising agent behind everything from whiter paper to cleaner drinking water - operating a single, fully integrated plant in Kalyan, Maharashtra that alone accounts for roughly half the country’s total production capacity. Born in 1954 and part of the Wadia Group, the company was reshaped through a demerger effective April 2022 that separated the chemicals business from investments and leasing, creating the pure-play listed entity that began trading on the BSE in July 2024. The recurring approach is industrial focus at scale: one site, one core chemistry, and a deliberate push to turn a commodity chemical into a platform by layering on derivative products and captive renewable power. # Business segments A single-engine specialty chemical company built around one molecule - hydrogen peroxide - with a small but growing renewable-energy captive supplying its plant. ## 1. Peroxygen chemicals: the molecule that runs the factory **One integrated plant makes hydrogen peroxide and its downstream derivatives, sold into more than half a dozen industries across over 30 countries, with no single customer dominating the book.** - **Half the nation’s capacity** - the Kalyan facility can produce 150,000 metric tonnes per annum of hydrogen peroxide (on a 50% weight-by-weight basis), which represents nearly 50% of India’s total installed manufacturing capacity for the chemical. - **One chemistry, many end markets** - hydrogen peroxide works as a bleaching agent for pulp, paper and textiles, an oxidising agent for water treatment and electronics cleaning, and a reducing agent in chemical synthesis, so demand is spread across unrelated industries. - **Derivatives stretch the molecule further** - the plant also produces peracetic acid, a biocide made from hydrogen peroxide that is sold as a disinfectant into food processing, healthcare and wastewater treatment, along with compressed hydrogen gas for other industrial uses. - **Exports without customer concentration** - finished goods reach more than 30 countries, yet no single buyer accounts for 10% or more of total revenue, which limits bargaining power on any one relationship. - **Gas supply locked in** - a long-term contract with GAIL for natural gas, the key feedstock, included a take-or-pay clause for a fixed annual quantity, giving cost visibility on the largest variable input through at least end-2025. ## 2. Captive renewable power: cheaper electrons for the chemical plant **A minority stake in a hybrid wind-and-solar project feeds dedicated green electricity to the Kalyan factory, cutting the energy bill without tying up the balance sheet.** - **Built through a special-purpose vehicle** - the company holds a 26% equity stake in Clean Max Bryce Private Limited, an SPV formed with a renewable-energy developer, so the project sits off the main balance sheet while still supplying the plant. - **Two sources, one connection** - the SPV delivers 6.6 MVA of wind energy and 3.30 MWp DC (2.20 MW AC) of solar energy directly to the Ambivali, Kalyan site, combining generation types to smooth out intermittency. # Group structure and partners **A standalone listed entity with no subsidiaries or joint ventures, backed by a century-old Indian conglomerate and a single blue-chip banker.** - **Pure-play, no group tangle** - as of March 2025 the company has no subsidiary, associate or joint venture, so all operating cash flows are generated at the listed entity level. - **Wadia Group parentage** - NPL sits inside a diversified conglomerate with interests spanning consumer goods, healthcare, real estate, aviation and electronics, and has historically received intercorporate deposits from fellow group companies. - **Single banking relationship** - Standard Chartered Bank is the company’s banker, and India Ratings has assigned a credit rating of ‘IND A/Stable/IND A1’ to its debt facilities. - **Leadership** - the board is chaired by Mr. Ness N. Wadia, with Mr. Rajiv Arora serving as CEO and Executive Director.

Documents — National Peroxide Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/wbg29n71bey5pv5vunyjia5v.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/krh7zccchmgtv63ouclfcwwa.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/i7i6hxrnt9fze5y2ml6kbuyq.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/2fzwfpusvktconxmn4rq7y3w.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/lf4as1xidnmluaxaks5cdb6y.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/aa3onqzy9lxaeaqvx07gnals.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/qgfvz637c2qi1v4o75q02oyj.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/suda796wyu1inn57nuhwfo0p.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/1jkh7z8yxla51m4gwww4d1dg.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/01n1yxg18klldmn4kh9qltlg.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/wm1vyr95jy3u03dpl4zi83ia.pdf